MENU

ALEC Alector Forecast, Technical & Fundamental Analysis

a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders

Industry Biotechnology
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALEC is expected to report earnings to rise 42.02% to -61 cents per share on April 01

Alector ALEC Stock Earnings Reports
Q4'24
Est.
$-0.61
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.10
Q1'24
Beat
by $0.13
Q4'23
Beat
by $0.29
The last earnings report on November 06 showed earnings per share of -43 cents, beating the estimate of -53 cents. With 1.04M shares outstanding, the current market capitalization sits at 185.09M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
244
Web
https://www.alector.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ALEC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with PSTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then PSTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
-4.55%
PSTX - ALEC
49%
Loosely correlated
-0.11%
PGEN - ALEC
48%
Loosely correlated
+2.46%
DNLI - ALEC
47%
Loosely correlated
-0.30%
BEAM - ALEC
46%
Loosely correlated
-1.21%
ABOS - ALEC
46%
Loosely correlated
-0.51%
More